Simplified Monopalmitoyl Toll‐like Receptor 2 Ligand Mini‐UPam for Self‐Adjuvanting Neoantigen‐Based Synthetic Cancer Vaccines
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Simplified Monopalmitoyl Toll‐like Receptor 2 Ligand Mini‐UPam for Self‐Adjuvanting Neoantigen‐Based Synthetic Cancer Vaccines ; year:2020
ChemBioChem ; (2020)
- Urheber
-
van den Ende, Thomas C.
Heuts, Jeroen M. M.
Gential, Geoffroy P. P.
Visser, Marten
van de Graaff, Michel J.
Ho, Nataschja I.
Jiskoot, Wim
Valentijn, A. Rob P. M.
Meeuwenoord, Nico J.
Overkleeft, Herman S.
Codée, Jeroen D. C.
van der Burg, Sjoerd H.
Verdegaal, Els M. E.
van der Marel, Gijsbert A.
Ossendorp, Ferry
Filippov, Dmitri V.
- DOI
-
10.1002/cbic.202000687
- URN
-
urn:nbn:de:101:1-2021020412565939220003
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:23 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- van den Ende, Thomas C.
- Heuts, Jeroen M. M.
- Gential, Geoffroy P. P.
- Visser, Marten
- van de Graaff, Michel J.
- Ho, Nataschja I.
- Jiskoot, Wim
- Valentijn, A. Rob P. M.
- Meeuwenoord, Nico J.
- Overkleeft, Herman S.
- Codée, Jeroen D. C.
- van der Burg, Sjoerd H.
- Verdegaal, Els M. E.
- van der Marel, Gijsbert A.
- Ossendorp, Ferry
- Filippov, Dmitri V.
Ähnliche Objekte (12)
Personalized neoantigen-pulsed dendritic cell vaccines show superior immunogenicity to neoantigen-adjuvant vaccines in mouse tumor models
Optimized polyepitope neoantigen DNA vaccines elicit neoantigen-specific immune responses in preclinical models and in clinical translation
NitraTh epitope-based neoantigen vaccines for effective tumor immunotherapy
Neoantigen‐based vaccines as a promising strategy in cancer immunotherapeutics
Neoantigen DNA vaccines are safe, feasible, and induce neoantigen-specific immune responses in triple-negative breast cancer patients
Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators
Personalized neoantigen cancer vaccines: current progression, challenges and a bright future
Correction to: Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators
Alanine-based spacers promote an efficient antigen processing and presentation in neoantigen polypeptide vaccines
Comparison of personal and shared frameshift neoantigen vaccines in a mouse mammary cancer model
Evaluation of the antitumor effect of neoantigen peptide vaccines derived from the translatome of lung cancer
Breast cancer vaccines: maximizing peptide-based vaccines by regulatory T cell depletion and toll-like receptor 9 activation
Personalized neoantigen-pulsed dendritic cell vaccines show superior immunogenicity to neoantigen-adjuvant vaccines in mouse tumor models
Optimized polyepitope neoantigen DNA vaccines elicit neoantigen-specific immune responses in preclinical models and in clinical translation
NitraTh epitope-based neoantigen vaccines for effective tumor immunotherapy
Neoantigen‐based vaccines as a promising strategy in cancer immunotherapeutics
Neoantigen DNA vaccines are safe, feasible, and induce neoantigen-specific immune responses in triple-negative breast cancer patients
Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators
Personalized neoantigen cancer vaccines: current progression, challenges and a bright future
Correction to: Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators
Alanine-based spacers promote an efficient antigen processing and presentation in neoantigen polypeptide vaccines
Comparison of personal and shared frameshift neoantigen vaccines in a mouse mammary cancer model
Evaluation of the antitumor effect of neoantigen peptide vaccines derived from the translatome of lung cancer
Breast cancer vaccines: maximizing peptide-based vaccines by regulatory T cell depletion and toll-like receptor 9 activation
Personalized neoantigen-pulsed dendritic cell vaccines show superior immunogenicity to neoantigen-adjuvant vaccines in mouse tumor models
Optimized polyepitope neoantigen DNA vaccines elicit neoantigen-specific immune responses in preclinical models and in clinical translation
NitraTh epitope-based neoantigen vaccines for effective tumor immunotherapy
Neoantigen‐based vaccines as a promising strategy in cancer immunotherapeutics
Neoantigen DNA vaccines are safe, feasible, and induce neoantigen-specific immune responses in triple-negative breast cancer patients
Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators
Personalized neoantigen cancer vaccines: current progression, challenges and a bright future
Correction to: Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators
Alanine-based spacers promote an efficient antigen processing and presentation in neoantigen polypeptide vaccines
Comparison of personal and shared frameshift neoantigen vaccines in a mouse mammary cancer model
Evaluation of the antitumor effect of neoantigen peptide vaccines derived from the translatome of lung cancer